Loading…
Orbicular Pharmaceutical Technologies
Accepting projectsPerformance Excellence - Delivered
Capabilities & focus
Process-development services
Formulation developmentAnalytical method developmentProduct development and late-stage licensing
Technology platforms
CI-TOP SPIN development strategy. Complex injectables: microspheresnanosuspensionsnano-emulsionsliposomeshigh-end peptidesdepot suspension injectionsdevice-based peptide injections. Parenterals: SDVMDVampouleslyophilised systemspre-filled syringesdry powders. Topicals: creamsemulsionsointmentsgelsfoamssolutions. Ophthalmics: dropssuspensionsgelsmicro-emulsionspreservative-free systems. Nasal sprays and inhalation solutions. Also states CR/MR diffusion and osmotic systemsmultiparticulate systemsenteric-coated and gastro-retentive systemsand that it handles cytotoxics and high-potent compounds. Development spans pre-formulationbench/lab scalescale-up process evaluationsubmission batches and technology transfer to partner or third-party cGMP sites; QbD is stated as its design approach.
Private
Ownership
ORB
Orbicular Pharmaceutical Technologies
Process development org · India
Live record · illustrative seed data · scores deterministic, rules-based — not AI. Not a regulatory determination or endorsement.